These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 35801755)
1. Associations of HIV persistence, cigarette smoking, inflammation, and pulmonary dysfunction in people with HIV on antiretroviral therapy. Cyktor J; Qin S; Staines B; Nouraie M; Fitzpatrick M; Kessinger C; DeSensi R; Huang L; Rinaldo CR; Kingsley L; Tien PC; Mellors JW; Morris A Medicine (Baltimore); 2022 Jul; 101(27):e29264. PubMed ID: 35801755 [TBL] [Abstract][Full Text] [Related]
2. Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts. N'takpe JB; Gabillard D; Moh R; Gardiennet E; Emieme A; Badje A; Kouame GM; Toni TD; Karcher S; Carrou JL; Ménan H; Danel C; Eholie SP; Rouzioux C; Anglaret X EBioMedicine; 2020 Jun; 56():102815. PubMed ID: 32512517 [TBL] [Abstract][Full Text] [Related]
3. Cellular HIV-1 DNA levels in patients receiving antiretroviral therapy strongly correlate with therapy initiation timing but not with therapy duration. Watanabe D; Ibe S; Uehira T; Minami R; Sasakawa A; Yajima K; Yonemoto H; Bando H; Ogawa Y; Taniguchi T; Kasai D; Nishida Y; Yamamoto M; Kaneda T; Shirasaka T BMC Infect Dis; 2011 May; 11():146. PubMed ID: 21605468 [TBL] [Abstract][Full Text] [Related]
5. Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged suppression of plasma HIV-1 RNA in children. Saitoh A; Hsia K; Fenton T; Powell CA; Christopherson C; Fletcher CV; Starr SE; Spector SA J Infect Dis; 2002 May; 185(10):1409-16. PubMed ID: 11992275 [TBL] [Abstract][Full Text] [Related]
6. Novel Assays for Measurement of Total Cell-Associated HIV-1 DNA and RNA. Hong F; Aga E; Cillo AR; Yates AL; Besson G; Fyne E; Koontz DL; Jennings C; Zheng L; Mellors JW J Clin Microbiol; 2016 Apr; 54(4):902-11. PubMed ID: 26763968 [TBL] [Abstract][Full Text] [Related]
7. Comparative Analysis of Cell-Associated HIV DNA Levels in Cerebrospinal Fluid and Peripheral Blood by Droplet Digital PCR. de Oliveira MF; Gianella S; Letendre S; Scheffler K; Kosakovsky Pond SL; Smith DM; Strain M; Ellis RJ PLoS One; 2015; 10(10):e0139510. PubMed ID: 26431315 [TBL] [Abstract][Full Text] [Related]
8. Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success. Alteri C; Scutari R; Stingone C; Maffongelli G; Brugneti M; Falasca F; Martini S; Bertoli A; Turriziani O; Sarmati L; Coppola N; Andreoni M; Santoro MM; Perno CF; Ceccherini-Silberstein F; Svicher V J Clin Virol; 2019 Aug; 117():61-67. PubMed ID: 31229934 [TBL] [Abstract][Full Text] [Related]
9. Dynamics of cellular HIV-1 DNA levels over 144 weeks of darunavir/ritonavir monotherapy versus triple therapy in the MONET trial. Geretti AM; Arribas JR; Lathouwers E; Foster GM; Yakoob R; Kinloch S; Hill A; van Delft Y; Moecklinghoff C HIV Clin Trials; 2013; 14(1):45-50. PubMed ID: 23372114 [TBL] [Abstract][Full Text] [Related]
10. Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapy. Zheng L; Bosch RJ; Chan ES; Read S; Kearney M; Margolis DM; Mellors JW; Eron JJ; Gandhi RT; Antivir Ther; 2013; 18(1):39-43. PubMed ID: 22914318 [TBL] [Abstract][Full Text] [Related]
11. HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens. Ghosn J; Leruez-Ville M; Blanche J; Delobelle A; Beaudoux C; Mascard L; Lecuyer H; Canestri A; Landman R; Zucman D; Ponscarme D; Rami A; Viard JP; Spire B; Rouzioux C; Costagliola D; Suzan-Monti M; Clin Infect Dis; 2014 Jun; 58(12):1763-70. PubMed ID: 24647014 [TBL] [Abstract][Full Text] [Related]
12. Brief Report: No Evidence for an Association Between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART. Bedimo RJ; Mar H; Bosch RJ; Drechsler H; Cyktor JC; Macatangay BJC; Lalama C; Rinaldo C; Collier A; Godfrey C; Hogg E; Hensel C; Eron JJ; Mcmahon DK; Mellors JW; Tebas P; Gandhi RT; J Acquir Immune Defic Syndr; 2019 Oct; 82(2):e27-e31. PubMed ID: 31335587 [TBL] [Abstract][Full Text] [Related]
13. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. Yukl SA; Gianella S; Sinclair E; Epling L; Li Q; Duan L; Choi AL; Girling V; Ho T; Li P; Fujimoto K; Lampiris H; Hare CB; Pandori M; Haase AT; Günthard HF; Fischer M; Shergill AK; McQuaid K; Havlir DV; Wong JK J Infect Dis; 2010 Nov; 202(10):1553-61. PubMed ID: 20939732 [TBL] [Abstract][Full Text] [Related]
14. Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load. Kostrikis LG; Touloumi G; Karanicolas R; Pantazis N; Anastassopoulou C; Karafoulidou A; Goedert JJ; Hatzakis A; J Virol; 2002 Oct; 76(20):10099-108. PubMed ID: 12239284 [TBL] [Abstract][Full Text] [Related]
15. Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during four-drug combination therapy. Tamalet C; Lafeuillade A; Fantini J; Poggi C; Yahi N AIDS; 1997 Jun; 11(7):895-901. PubMed ID: 9189215 [TBL] [Abstract][Full Text] [Related]
16. A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir. Piketty C; Weiss L; Assoumou L; Burgard M; Mélard A; Ragnaud JM; Bentata M; Girard PM; Rouzioux C; Costagliola D; J Med Virol; 2010 Nov; 82(11):1819-28. PubMed ID: 20872707 [TBL] [Abstract][Full Text] [Related]
17. Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy. Lee SA; Bacchetti P; Chomont N; Fromentin R; Lewin SR; O'Doherty U; Palmer S; Richman DD; Siliciano JD; Yukl SA; Deeks SG; Burbelo PD PLoS One; 2016; 11(8):e0160192. PubMed ID: 27483366 [TBL] [Abstract][Full Text] [Related]
18. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. Furtado MR; Callaway DS; Phair JP; Kunstman KJ; Stanton JL; Macken CA; Perelson AS; Wolinsky SM N Engl J Med; 1999 May; 340(21):1614-22. PubMed ID: 10341273 [TBL] [Abstract][Full Text] [Related]
19. HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment. Burgard M; Izopet J; Dumon B; Tamalet C; Descamps D; Ruffault A; Vabret A; Bargues G; Mouroux M; Pellegrin I; Ivanoff S; Guisthau O; Calvez V; Seigneurin JM; Rouzioux C AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1939-47. PubMed ID: 11153076 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial oxidative phosphorylation in peripheral blood mononuclear cells is decreased in chronic HIV and correlates with immune dysregulation. Gangcuangco LMA; Mitchell BI; Siriwardhana C; Kohorn LB; Chew GM; Bowler S; Kallianpur KJ; Chow DC; Ndhlovu LC; Gerschenson M; Shikuma CM PLoS One; 2020; 15(4):e0231761. PubMed ID: 32353005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]